Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04193579 · ClinicalTrials.gov registry record · NA
Listening to Mom 2: Neural, Clinical and Language Outcomes
A NA study of Premature Birth, sponsored by Stanford University.
- Active
- Registry status
- NA
- Development phase
- 57
- Enrollment target
- 1
- Study location
NCT04193579: Active NA study of Premature Birth, sponsored by Stanford University.
NCT04193579 is a NA study of Premature Birth that is active but no longer recruiting, run by Stanford University. The registered enrollment target is 57 participants, below the 393-participant average among 38 other Premature Birth trials with a reported enrollment target (85% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04193579, a NA study of Premature Birth, is active but no longer recruiting, sponsored by Stanford University.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 57 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to examine whether playing recordings of a mother's voice to her infant while in the hospital nursery is an effective treatment for promoting healthy brain and language development in infants born preterm.
Primary Outcome
Parent questionnaire of receptive and expressive language skills. Will be used to assess the long-term impact of intervention on language outcomes. Standard scores are based on percentiles for age and sex and range from \<1 to 99th percentile. Raw scores range from 0 to 680. Both higher standard scores and raw scores indicate better performance.
Conditions Studied
Interventions
- BEHAVIORAL Language Treatment
- BEHAVIORAL Control Treatment
Study Locations (1)
California
- Stanford University - Lucile Packard Children's Hospital - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 57 participants |
| Start Date | 2019-11-25 |
| Est. Completion | 2026-03-01 |
| Phase | NA |
What the registry record for NCT04193579 still lists
NCT04193579 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 57 participants, a relatively small participant target, below the 393-participant average among 38 other Premature Birth trials with a reported enrollment target (85% lower).
The record links to 1 condition, with Premature Birth appearing as the primary indexed condition, and to 2 interventions - of which Language Treatment is the first listed.
NCT04193579 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT04193579 about?
NCT04193579 is a clinical study titled "Listening to Mom 2: Neural, Clinical and Language Outcomes". The purpose of this study is to examine whether playing recordings of a mother's voice to her infant while in the hospital nursery is an effective treatment for promoting healthy brain and language development in infants born preterm.
What is the current status of trial NCT04193579?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 57 participants. The study started on 2019-11-25. Estimated completion is 2026-03-01.
What conditions does trial NCT04193579 study?
This clinical trial studies the following conditions: Premature Birth.
What interventions are being tested in trial NCT04193579?
The interventions under investigation include: Language Treatment (BEHAVIORAL), Control Treatment (BEHAVIORAL).
Who is sponsoring clinical trial NCT04193579?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04193579 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Premature Birth
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04193579's enrollment target sits among peer trials
57 31st of 38 higher than 8 of 38 other Premature Birth trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Premature Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Randomized Controlled Trial of Impact of Wearable, Wireless Breast Pumps on Frequency and Efficacy of Milk Expression in Mothers of Premature Infants
RECRUITING · NA
-
Optimizing Family Counseling for Anticipated Extremely Preterm Delivery
RECRUITING · NA
-
The Periviable GOALS Decision Support Tool
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Development of a Therapeutic Device to Improve Speech Sound Differentiation in Preterm Infants
RECRUITING · NA
-
Healing Tiny Minds: Rural Recovery Through Virtual and Lived Experience Care
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03521830 · 57 participants · Phase 2
Nivolumab Alone or Plus Relatlimab or Ipilimumab for Patients With Locally-Advanced Unresectable or Metastatic Basal Cell Carcinoma
- NCT03587701 · 57 participants · Phase 2
Effects of Anakinra in Subjects With Corticosteroid-resistant/Intolerant Meniere's Disease and Autoimmune Inner Ear Disease
- NCT04104126 · 57 participants · NA
Blood Flow Restriction Therapy in Achilles Injury
- NCT04703842 · 57 participants · Phase 1
Modulation of SERCA2a of Intra-myocytic Calcium Trafficking in Heart Failure With Reduced Ejection Fraction
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI